Geron Corporation (GERN): Price and Financial Metrics

GERN POWR Grades

• Quality is the dimension where GERN ranks best; there it ranks ahead of 47.8% of US stocks.
• The strongest trend for GERN is in Momentum, which has been heading down over the past 179 days.
• GERN's current lowest rank is in the Sentiment metric (where it is better than 9.7% of US stocks).

GERN Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for GERN is 0.01 -- better than merely 7.04% of US stocks.
• GERN's price/sales ratio is 297.47; that's higher than the P/S ratio of 98.82% of US stocks.
• Revenue growth over the past 12 months for Geron Corp comes in at 450.59%, a number that bests 98.13% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to Geron Corp are VTGN, STTK, VBLT, GNCA, and AYLA.
• GERN's SEC filings can be seen here. And to visit Geron Corp's official web site, go to www.geron.com.

GERN Valuation Summary

• GERN's price/sales ratio is 1156.5; this is 30334.21% higher than that of the median Healthcare stock.
• Over the past 243 months, GERN's price/sales ratio has gone up 1098.9.
• GERN's EV/EBIT ratio has moved up 6.1 over the prior 243 months.

Below are key valuation metrics over time for GERN.

GERN Growth Metrics

The 4 year price growth rate now stands at -40.37%.
• The 4 year cash and equivalents growth rate now stands at 57.35%.
• Its 4 year net cashflow from operations growth rate is now at -159.57%.

Over the past 70 months, GERN's revenue has gone down $35,190,000.

The table below shows GERN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	1.393	-95.556	-116.112
2021-09-30	0.403	-86.002	-107.882
2021-06-30	0.402	-78.611	-100.836
2021-03-31	0.338	-73.192	-87.086
2020-12-31	0.253	-66.652	-75.617
2020-09-30	0.374	-64.404	-80.9

GERN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• GERN has a Quality Grade of C, ranking ahead of 52.18% of graded US stocks.
• GERN's asset turnover comes in at 0.002 -- ranking 426th of 682 Pharmaceutical Products stocks.
• NSTG, NEOG, and CLVS are the stocks whose asset turnover ratios are most correlated with GERN.

The table below shows GERN's key quality metrics over time.